Story thread · 12 reports / 11 sources
Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors
medpagetoday.com · 6d
How the coverage leans
Across 11 sources · syndicated copies counted once
(MedPage Today) -- The FDA on Friday granted accelerated approval to camizestrant (Etcamah) for treating hormone receptor-positive/HER2-negative breast cancer at the first sign of ESR1 resistance mutations during first-line treatment. Camizestrant...
First report: 'I thought it was a gym injury' but man's pea-sized lump was stage 3 breast cancer — mirror.co.uk, 9d
The coverage
- FDA Approves New Pill For Advanced Breast Cancer Guided By Blood Test
drugs.com · 6d
- FDA approves 1st-of-its-kind breast cancer treatment
beckershospitalreview.com · 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.